Nasdaq leads US exchanges for Q1 IPOs
Nasdaq OMX Group has announced that in the first quarter of 2014 it has had 74 new listings, including 45 IPOs, more than double the number of IPOs of any other US exchange.
Combined proceeds raised by Nasdaq's first quarter IPOs totalled approximately $2.6bn, a 20% increase from first quarter figures for 2013. In addition, 98% of these IPOs filed as ‘emerging growth companies’, the new class of issuer created under the Jobs Act.
Nasdaq's first quarter IPOs have returned on average an increase of 28.2% from their offer price, above the market average return for all US IPOs of 24.3%.
Thirty two healthcare companies listed in the first quarter, buoyed by a pipeline of 22 biotech listings. All biotechnology IPOs in the US in 2014 to date have listed on Nasdaq and healthcare IPOs are up an average of 30% from their offer price.
Nasdaq has listed eight financial companies and three technology companies in the first quarter. Its technology IPOs in 2014 are up an average of 53.2% from their offer price to date and 92% of venture capital-backed IPOs have listed with Nasdaq. Venture capital and private equity-sponsored IPOs raised more than $1.9bn in combined proceeds.
Combined proceeds raised by Nasdaq's first quarter IPOs totalled approximately $2.6bn, a 20% increase from first quarter figures for 2013. In addition, 98% of these IPOs filed as ‘emerging growth companies’, the new class of issuer created under the Jobs Act.
Nasdaq's first quarter IPOs have returned on average an increase of 28.2% from their offer price, above the market average return for all US IPOs of 24.3%.
Thirty two healthcare companies listed in the first quarter, buoyed by a pipeline of 22 biotech listings. All biotechnology IPOs in the US in 2014 to date have listed on Nasdaq and healthcare IPOs are up an average of 30% from their offer price.
Nasdaq has listed eight financial companies and three technology companies in the first quarter. Its technology IPOs in 2014 are up an average of 53.2% from their offer price to date and 92% of venture capital-backed IPOs have listed with Nasdaq. Venture capital and private equity-sponsored IPOs raised more than $1.9bn in combined proceeds.
Found this useful?
Take a complimentary trial of the FOW Marketing Intelligence Platform – the comprehensive source of news and analysis across the buy- and sell- side.
Gain access to:
- A single source of in-depth news, insight and analysis across Asset Management, Securities Finance, Custody, Fund Services and Derivatives
- Our interactive database, optimized to enable you to summarise data and build graphs outlining market activity
- Exclusive whitepapers, supplements and industry analysis curated and published by Futures & Options World
- Breaking news, daily and weekly alerts on the markets most relevant to you
